We are live on
!
Find out more
AIM
Aigen Investment Management Portfolio holdings
AUM
$389M
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
-28.09%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$753M
AUM Growth
+$149M
(+25%)
Cap. Flow
+$464M
Cap. Flow
% of AUM
61.59%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,737
New
568
Increased
434
Reduced
241
Closed
491
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$11.5M |
| 2 |
Nucor
NUE
|
+$9.58M |
| 3 |
Microsoft
MSFT
|
+$9.57M |
| 4 |
Duke Energy
DUK
|
+$9.38M |
| 5 |
Costco
COST
|
+$7.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$10M |
| 2 |
FirstEnergy
FE
|
+$7.33M |
| 3 |
Exelon
EXC
|
+$6.32M |
| 4 |
Cincinnati Financial
CINF
|
+$6.04M |
| 5 |
Johnson Controls International
JCI
|
+$5.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.54% |
| 2 | Healthcare | 14.02% |
| 3 | Financials | 13.64% |
| 4 | Consumer Discretionary | 11.63% |
| 5 | Industrials | 11.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Kearny Financial
KRNY
$600M
| $14K | ﹤0.01% |
+1,650
| New | +$19K |
|
1127
United Therapeutics
UTHR
$22.1B
| $14K | ﹤0.01% |
150
-1,772
| -92% | -$168K |
|
|
MDC
1128
DELISTED
M.D.C. Holdings, Inc.
MDC
| $14K | ﹤0.01% |
670
+668
| +33,400% | +$23.4K |
|
|
QTNT
1129
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $14K | ﹤0.01% |
+90
| New | +$23.6K |
|
|
NP
1130
DELISTED
Neenah, Inc. Common Stock
NP
| $14K | ﹤0.01% |
331
-2,087
| -86% | -$124K |
|
1131
AtriCure
ATRC
$2.18B
| $13K | ﹤0.01% |
+397
| New | +$14.3K |
|
1132
Harmonic Inc
HLIT
$1.24B
| $13K | ﹤0.01% |
2,326
+2,254
| +3,131% | +$15.1K |
|
1133
MYR Group
MYRG
$5.14B
| $13K | ﹤0.01% |
+498
| New | +$14K |
|
1134
Protolabs
PRLB
$2.16B
| $13K | ﹤0.01% |
168
-2,649
| -94% | -$245K |
|
|
AXNX
1135
DELISTED
Axonics, Inc. Common Stock
AXNX
| $13K | ﹤0.01% |
+512
| New | +$15.2K |
|
|
SCWX
1136
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $12K | ﹤0.01% |
+1,009
| New | +$14.4K |
|
|
OPB
1137
DELISTED
Opus Bank Common Stock
OPB
| $12K | ﹤0.01% |
699
-1,943
| -74% | -$45.3K |
|
1138
Altisource Portfolio Solutions
ASPS
$63.7M
| $11K | ﹤0.01% |
186
+112
| +151% | +$14.1K |
|
1139
Bruker
BRKR
$8.69B
| $11K | ﹤0.01% |
+303
| New | +$14K |
|
1140
Collegium Pharmaceutical
COLL
$843M
| $11K | ﹤0.01% |
657
-16,271
| -96% | -$336K |
|
1141
Harley-Davidson
HOG
$2.78B
| $11K | ﹤0.01% |
+573
| New | +$17.3K |
|
|
HTBK
1142
DELISTED
Heritage Commerce
HTBK
| $11K | ﹤0.01% |
1,411
-4,885
| -78% | -$51.7K |
|
1143
Myers Industries
MYE
$1.21B
| $11K | ﹤0.01% |
1,065
-11,194
| -91% | -$163K |
|
|
IBKC
1144
DELISTED
IBERIABANK Corp
IBKC
| $11K | ﹤0.01% |
+312
| New | +$19.4K |
|
1145
APA Corp
APA
$14.2B
| $10K | ﹤0.01% |
2,272
-1,680
| -43% | -$37.4K |
|
1146
Criteo S.A. Ordinary Shares
CRTO
$867M
| $10K | ﹤0.01% |
+1,201
| New | +$15.3K |
|
1147
Heartland Express
HTLD
$914M
| $9K | ﹤0.01% |
508
+397
| +358% | +$7.54K |
|
1148
Olin
OLN
$2.17B
| $9K | ﹤0.01% |
770
-4,467
| -85% | -$67.6K |
|
1149
Service Corp International
SCI
$11.4B
| $9K | ﹤0.01% |
+219
| New | +$10.2K |
|
1150
Hubbell
HUBB
$27.5B
| $8K | ﹤0.01% |
+72
| New | +$9.71K |
|
Similar funds
WCM
PFPGI
PG
SI
TCM
HBWM
DAM
EC
Aigen Investment Management's Q1 2020 Portfolio in Review
As of Q1 2020, Aigen Investment Management held 1,737 positions worth $753M, up 25% from $604M the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Aigen Investment Management deployed $464M of net new capital in Q1 2020, opening 568 new positions and adding to 434 existing holdings. Its largest new stake was Nucor: 215,804 shares worth $7.77M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $10M trimmed.
- Aigen Investment Management's largest Q1 2020 buy was Nucor: 215,804 shares worth $7.77M.
- Aigen Investment Management added most to Thermo Fisher Scientific in Q1 2020, an estimated $11.5M increase.
- Aigen Investment Management's biggest Q1 2020 reduction was Zoetis, cutting an estimated $10M.
- Aigen Investment Management fully exited FirstEnergy in Q1 2020, selling an estimated $7.33M.
- Aigen Investment Management's ten largest holdings make up 9.4% of its $753M portfolio in Q1 2020.
- Aigen Investment Management opened 568 new positions and closed 491 in Q1 2020.
- Aigen Investment Management's portfolio value rose 25% quarter-over-quarter to $753M.
Based on Aigen Investment Management's 13F filing for Q1 2020, filed 8 May 2020.